US$ 25.42
glp 1 agonist parkinson GLP-1/GIP dual tirzepatide alleviates mice model of Parkinson's disease by promoting mitochondrial homeostasis How do GLP-1 agonists like
Description
Conflict of Interest Statement S.L.B
Are these drugs truly the miracle some claim they are, or is the hype overshadowing the risks

In: American Diabetes Associations 77th Scientific Sessions

doi: 10.2337/dc18-1446 [DOI] [PubMed] [Google Scholar] 22

Over-reliance on pharmacotherapy without adequate commitment to lifestyle interventions may obfuscate underlying etiologies

Diabetes and Obesity: The Twin Epidemics
